Bio-Path (NASDAQ:BPTH) Receives New Coverage from Analysts at began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Monday morning. The firm issued a sell rating on the stock. Bio-Path Stock Performance Shares of NASDAQ:BPTH opened at $0.63 on Monday. The business’s 50 day simple moving average is $0.43 and its two-hundred day simple moving average is […]

Leave a Reply

Your email address will not be published.

Previous post ClearSign Technologies (NASDAQ:CLIR) Earns Sell Rating from Analysts at
Next post Russian machine tool industry looks to recover Soviet era glory